We previously provided evidence that the downregulation of NPC2 is correlated with the α-fetoprotein level, tumor type, vascular invasion, and pathology stages of hepatocellular carcinoma (HCC) patients. This evidence concerns the gene NPC2 and hepatocellular carcinoma.